XTNT xtantmedical.com: Debts to Book Capitalization

Corporate company logo of xtantmedical.com (XTNT)

Stabilization of management following mergers allowed Xtant Medical Holdings (XTNT) to optimize its debt load. The debt-to-capitalization ratio reflects the dynamics of liability control, with the indicator maintained at 0.69. Clinic loyalty to bone grafting implants ensures consistent demand, while the increase in scheduled transplantations offsets macroeconomic risks, supporting a steady business uptrend.

Xtant Medical - XTNT Debts to Net Assets (period 07/04/2022 - 10/31/2026)
Original product of xtantmedical.com

Long-term investing requires strict control of credit loads to minimize default risks. For orthopedic implant market leader Xtant Medical (XTNT), the borrowing balance is critical for maintaining high product safety standards. This chart of total debt-to-equity reflects the proportion of liabilities relative to the company's own assets. An increase in this ratio signals a dangerous level of financial leverage. This metric determines the issuer's resilience in a tight market.

Direct competitors

Debts to Book Capitalization BSX (Boston Scientific)|edwards.com (EW) - Debts to Book Value|ResMed - Debts to Book Capitalization|Insulet Corp (PODD) - Debt to Book Value|ZBH: Debts to Book Capitalization|COO - Debts to Net Assets|ALGN (Align Technology, Inc.) - Debts to Book Capitalization|Debts to Book Capitalization globusmedical.com|Debt to Book Capitalization Ratio TransMedics Organ Care System (TMDX)|Debt to Book Capitalization Ratio ATEC (Alphatec Holdings)|Debts to Book Capitalization AORT (Artivion Inc)|Debts to Net Assets Enovis Inc. (ENOV)|IART: Debt to Book Value|Debts to Book Capitalization Ratio ESTA|BBNX: Debts to Book Capitalization|Debts to Book Value IRADIMED Corp (IRMD)|EMBC (Embecta Inc.) - Debts to Book Capitalization|Debt to Book Value Ratio TNDM (Tandem Corp)|Debt to Book Value AXGN (AxoGen, Inc.)|SIBN (si-bone.com) - Debt to Net Assets Ratio|Debt to Book Capitalization Ratio Orthofix OFIX|BVS - Debt to Book Value|OrthoPediatrics Inc. - Debts to Book Capitalization|Debts to Book Value Treace Corp|SRTA: Debts to Book Capitalization|Debt to Book Value Ratio CARL|RXST (RxSight) - Debts to Book Capitalization|ClearPoint (CLPT) - Debts to Net Assets|Debts to Book Capitalization STXS|Debt to Book Value Neuronetics, Inc STIM|Debts to Book Capitalization SGHT (Sight Sciences, Inc.)|Debts to Book Capitalization Orchestra BioMed Inc. OBIO|ANIK - Debt to Book Capitalization Ratio|NSPR: Debt to Book Capitalization Ratio|ZJYL (zhjmedical.com) - Debt to Book Value|Vivani Medical - Debt to Net Assets Ratio|NMTC (NeuroOne Medical Technologies) - Debts to Book Capitalization|Debts to Book Value Modular Med MODD|Debt to Book Capitalization Ratio Myomo (MYO)|Envoy Medical Inc. (COCH) - Debt to Net Assets|Vivos Therapeutics, Inc - Debt to Book Value|Debts to Book Capitalization enVVeno Corp NVNO|SINTX Technologies - Debts to Book Capitalization|Debts to Net Assets tenonmed.com TNON|Lifeward (LFWD) - Debt to Book Capitalization Ratio|Debts to Book Capitalization Ratio AMIX (Autonomix Medical)|Debt to Book Capitalization Ratio INVO Bioscience, Inc.|Debt to Book Value Bone Biologics Inc (BBLG)|Debts to Book Capitalization AXNX|BIOL - Debts to Book Value|Debt to Book Capitalization Ratio Dynatronics DYNT|FNA: Debt to Book Value Ratio|INVO: Debt to Book Value